Alex Cohen is the Director of Learning and Evaluation for the Richard M. Fairbanks Foundation.


In July 2019, the CDC released preliminary estimates that showed, for the first time since 1990, a decline in fatal drug poisonings (overdose deaths) in the United States—by approximately 5 percent from 2017 to 2018. This decline is borne out in Indiana and Marion County as well. In Indiana, data from the CDC and provisional data from the Indiana State Department of Health show a decline of more than 10%. Marion County, which has the highest fatal drug poisoning count in the state, saw a similar decline, according to data from the IU Public Policy Institute’s Center for Health and Justice Research.

That is, of course, great news. And while it’s difficult to know what drove the change, it provides at least some support for the myriad efforts to address the opioid epidemic—through expanded access to medication-assisted treatment, education to curb opioid prescribing and harm reduction efforts like naloxone distribution or syringe service programs, among many others.

However, as several have noted, it’s too early to declare that the fatal drug poisoning epidemic is over.

The drop in fatal drug poisonings from 2017 to 2018 was propelled largely by a decline in drug poisoning involving prescription opioids, which drove the so-called “first wave” of the opioid epidemic, and a flattening of deaths due to heroin, which drove the “second wave” of the epidemic.

However, the “third wave” of the epidemic—surging deaths due to the powerful synthetic opioid fentanyl—still seems underway. Fatal drug poisonings involving fentanyl continued to rise, though at a lower rate than previous years. Perhaps more troubling, however, drug poisonings involving other drugs—namely, cocaine and methamphetamine—also continued to rise, and one reason for this may be that meth and cocaine are increasingly being combined with fentanyl, making them more lethal than they are on their own.

But perhaps the biggest reason for caution is that opioids still claim a large number of lives. At nearly 70,000 per year nationwide, the number of fatal drug poisonings still far outpaces the number of deaths from car crashes, HIV and gun deaths at their peaks. This means there is still a strong need for prevention, treatment and harm reduction approaches. If the decline in fatal drug poisonings in 2018 were indeed driven by intensive efforts to address the opioid epidemic, we need to continue with these efforts at the same level of intensity. Failing to do so could cause deaths to creep back up.

Taken together, while the 2018 figures provide reason for optimism, there is still a continued need for vigilance—to make sure drops in fatal drug poisonings continue and that gains in addressing one part of the drug epidemic aren’t overtaken by new drugs.

Additional Posts

Fairbanks Foundation’s Commitment to Strengthening the City’s Key Economic Drivers: A Review of Grantmaking within our Vitality of Indianapolis Focus Area from 2015 to 2019

Claire Fiddian-Green is the President & CEO of the Richard M. Fairbanks Foundation. The life sciences sector is a major driver of Central Indiana’s economy and a key contributing factor to the vitality of Indianapolis. While Indiana’s life sciences sector is robust – wages for the sector have grown to $5.8 billion in 2018, and venture […]

We Must Act Now to Address the Youth E-Cigarette Epidemic

Claire Fiddian-Green is the President & CEO of the Richard M. Fairbanks Foundation. “When you see a rattlesnake poised to strike, you do not wait until he has struck to crush him.” –  Franklin D. Roosevelt E-cigarette use among youth has grown at an alarming rate. In 2017, over 2 million U.S. middle and high […]